Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States

Background. New therapies for castration-resistant prostate cancer (CRPC) may be associated with increased risk of second primary malignancies (SPM). We therefore estimated the population-based incidence of SPM among patients with CRPC in the Surveillance, Epidemiology, and End Results (SEER)-Medica...

Full description

Bibliographic Details
Main Authors: Catherine W. Saltus, Zdravko P. Vassilev, Jihong Zong, Brian Calingaert, Elizabeth B. Andrews, Montse Soriano-Gabarró, James A. Kaye
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2019/4387415